Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCAA Supplementation for Cirrhotic Patients With Sarcopenia
NCT06121492Phase 3Enrolling by invitation
- Sponsor
- Mahidol University
- Start
- Nov 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Sarcopenia comparing Branched-chain amino acid with Placebo (2 arms). Primary endpoint: Resolution of sarcopenia at 24 weeks. Started Nov 2023; status: enrolling by invitation.
02
Drugs
Branchamin
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT06121492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121492.